Cytokines and schizophrenia: Microglia hypothesis of schizophrenia

Akira Monji, Takahiro Kato, Shigenobu Kanba

Research output: Contribution to journalArticle

269 Citations (Scopus)

Abstract

The etiology of schizophrenia remains unclear, while there has been a growing amount of evidence for the neuroinflammation and immunogenetics, which are characterized by an increased serum concentration of several pro-inflammatory cytokines. Despite the fact that microglia comprise only <10% of the total brain cells, microglia respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia has recently been reported to be closely associatedwith microglial activation. Previous studies have shown the inhibitory effects of some typical/atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which have recently been known to cause a decrease in neurogenesis as well as white matter abnormalities in the brains of patients with schizophrenia. The microglia hypothesis of schizophrenia may shed new light on the therapeutic strategy for schizophrenia.

Original languageEnglish
Pages (from-to)257-265
Number of pages9
JournalPsychiatry and clinical neurosciences
Volume63
Issue number3
DOIs
Publication statusPublished - Jun 1 2009

Fingerprint

Microglia
Schizophrenia
Cytokines
Free Radicals
Brain
Immunogenetics
Neurogenesis
Antipsychotic Agents
Serum

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Cytokines and schizophrenia : Microglia hypothesis of schizophrenia. / Monji, Akira; Kato, Takahiro; Kanba, Shigenobu.

In: Psychiatry and clinical neurosciences, Vol. 63, No. 3, 01.06.2009, p. 257-265.

Research output: Contribution to journalArticle

@article{b6d82f67ce714fae9121c8edc372b9c1,
title = "Cytokines and schizophrenia: Microglia hypothesis of schizophrenia",
abstract = "The etiology of schizophrenia remains unclear, while there has been a growing amount of evidence for the neuroinflammation and immunogenetics, which are characterized by an increased serum concentration of several pro-inflammatory cytokines. Despite the fact that microglia comprise only <10{\%} of the total brain cells, microglia respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia has recently been reported to be closely associatedwith microglial activation. Previous studies have shown the inhibitory effects of some typical/atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which have recently been known to cause a decrease in neurogenesis as well as white matter abnormalities in the brains of patients with schizophrenia. The microglia hypothesis of schizophrenia may shed new light on the therapeutic strategy for schizophrenia.",
author = "Akira Monji and Takahiro Kato and Shigenobu Kanba",
year = "2009",
month = "6",
day = "1",
doi = "10.1111/j.1440-1819.2009.01945.x",
language = "English",
volume = "63",
pages = "257--265",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Cytokines and schizophrenia

T2 - Microglia hypothesis of schizophrenia

AU - Monji, Akira

AU - Kato, Takahiro

AU - Kanba, Shigenobu

PY - 2009/6/1

Y1 - 2009/6/1

N2 - The etiology of schizophrenia remains unclear, while there has been a growing amount of evidence for the neuroinflammation and immunogenetics, which are characterized by an increased serum concentration of several pro-inflammatory cytokines. Despite the fact that microglia comprise only <10% of the total brain cells, microglia respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia has recently been reported to be closely associatedwith microglial activation. Previous studies have shown the inhibitory effects of some typical/atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which have recently been known to cause a decrease in neurogenesis as well as white matter abnormalities in the brains of patients with schizophrenia. The microglia hypothesis of schizophrenia may shed new light on the therapeutic strategy for schizophrenia.

AB - The etiology of schizophrenia remains unclear, while there has been a growing amount of evidence for the neuroinflammation and immunogenetics, which are characterized by an increased serum concentration of several pro-inflammatory cytokines. Despite the fact that microglia comprise only <10% of the total brain cells, microglia respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia has recently been reported to be closely associatedwith microglial activation. Previous studies have shown the inhibitory effects of some typical/atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which have recently been known to cause a decrease in neurogenesis as well as white matter abnormalities in the brains of patients with schizophrenia. The microglia hypothesis of schizophrenia may shed new light on the therapeutic strategy for schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=65649134782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649134782&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1819.2009.01945.x

DO - 10.1111/j.1440-1819.2009.01945.x

M3 - Article

C2 - 19579286

AN - SCOPUS:65649134782

VL - 63

SP - 257

EP - 265

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 3

ER -